Tag: New York

news-05112024-172724

Medicaid Coverage of Obesity Drugs and Sickle Cell Trial Death: Pharmalittle Update

Good morning, everyone! We hope you're having a great day. Despite the cloudy skies here at Pharmalot, we're doing well and enjoying the autumn breeze. Today is an exciting day with millions of voters...
news-15112024-162300

Why Everyone Should Get a Flu Vaccine This Year

Flu Vaccine A number of flu vaccines will be available this season. These include:• injectable flu vaccines, or flu shots. These include:• Flu shots that are made with inactivated influenza viruses.• One flu shot that...
news-20112024-062138

RFK Jr. Considered for Health Secretary as Pharma Execs Seek Stability

Robert F. Kennedy Jr., a well-known critic of the pharmaceutical industry, has been considered for the position of Health Secretary. He has been vocal about his views on how the industry has influenced U.S....
news-22112024-142640

Optimistic Vaccine Activist: Embracing Hope for the Future

The United States is facing an uncertain future when it comes to vaccine policy. With potential appointees like Robert F. Kennedy Jr., Mehmet Oz, Jay Bhattacharya, and Joseph A. Ladapo, public health advocates are...
news-05112024-112139

Interview with FDA’s Top Vaccine Regulator: Addressing Disinformation

The vaccination policy in the United States may be facing some significant changes, especially if Donald Trump is reelected and follows through on promises made by vaccine skeptic Robert Kennedy Jr. However, amidst concerns...
news-15112024-102143

Nominate Vaccine Skeptic RFK Jr. to Run HHS: Trump’s Controversial Decision

President-elect Trump has selected Robert F. Kennedy Jr., an environmental lawyer and vaccine skeptic, as his choice to lead the Department of Health and Human Services. Trump made the announcement on Truth Social, expressing...
news-26112024-115233

Roche Lung Cancer Study: Immunotherapy Failures and Drug Target Questions

Roche, a pharmaceutical company, recently announced that an experimental cancer treatment they were working on, called tiragolumab, did not improve survival rates in a major lung cancer study. The study, known as SKYSCRAPER-01, involved...
news-08112024-220349

Inside the Therapist’s Room: A Look at the 2024 Election

I stand before my bathroom mirror, trying to calm my breathing. It's the morning after the election, and I just found out the results an hour ago. I've rushed through my morning routine, feeling...
news-17112024-061144

CRISPR Therapy Shows Superior Benefit for Cardiomyopathy Patients

Intellia Therapeutics CEO John Leonard has been facing a familiar situation for the past few years. The company has been sharing positive results from its gene editing trials, only to see its stock prices...
news-06112024-052955

Pharmacies Sue GoodRx and PBMs for Illegal Reimbursement Fees

Three independent pharmacies recently took legal action against GoodRx, a company that offers a prescription drug discount card, as well as several pharmacy benefit managers (PBMs). These lawsuits allege that GoodRx and the PBMs...
news-14112024-161449

Merck Expands Portfolio with Licensing of Chinese Cancer Drug

Merck, a leading pharmaceutical company, has recently taken a strategic step to enhance its cancer drug portfolio by acquiring the licensing rights for a new cancer drug from LaNova Medicines, a Chinese firm based...
news-18112024-001346

Alzheimer’s Drug Reversal & Bavarian Nordic’s Trump Views: Pharmalittle Update

As the week comes to an end, it's time to start thinking about weekend plans. Whether it's tidying up, taking a trip to see a college campus, or catching up on reading, there are...